Double-contrast magnetic resonance imaging of hepatocellular carcinoma after transarterial chemoembolization [PDF]
, 2018 Background: The purpose of this study was to assess the accuracy of double-contrast magnetic resonance (MR) imaging for the treatment response evaluation of hepatocellular carcinoma (HCC) in cirrhotic liver after transarterial chemoembolization (TACE ...
Andreisek, Gustav +4 more
core
BiomedicinesHepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide with an average five-year survival rate in the US of 19.6%.
Stephen Susman +2 more
doaj +1 more source
A cross sectional analysis of the association between FGF19 tumor expression and serum AFP levels in advanced HCC patients [PDF]
, 2017 PURPOSE: HCC is a complicated disease with high mortality rates and limited treatment options. No universal clinical or molecular classification established to inform better treatment options.
Clifford, Corinne
core
The prime time for management of hepatocellular carcinoma in Hong Kong [PDF]
Clinical and Molecular Hepatology, 2023 Landon L. Chan, Stephen L. Chan
doaj +1 more source
Hypersensitivity Reaction after Transarterial Chemoembolization [PDF]
Seminars in Interventional Radiology, 2020 Murad M, Alqadi +4 more
openaire +2 more sources
Extent of Embolization as an Independent Prognostic Factor in Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma. [PDF]
J Hepatocell CarcinomaOkumura K +6 more
europepmc +1 more source
Nontarget embolization of the hepatic falciform artery in the treatment of hepatocellular carcinoma: Case report and review of the literature. [PDF]
Radiol Case RepLai M +4 more
europepmc +1 more source
Partial splenic embolization plus antitumor therapy for treating patients with hepatocellular carcinoma and splenomegaly: a case series study. [PDF]
J Gastrointest OncolLi B, Jiang B, Pang X, Ji M.
europepmc +1 more source